scholarly article | Q13442814 |
P50 | author | Khaled M Aboshanab | Q59687607 |
Walid El-Khatib | Q80551370 | ||
P2093 | author name string | Mai M Helmy | |
Hadir A El-Mahallawy | |||
Samira M Hamed | |||
Mohamed S Ashour | |||
P2860 | cites work | Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes | Q24625992 |
Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. | Q30240591 | ||
qnrE1, a Member of a New Family of Plasmid-Located Quinolone Resistance Genes, Originated from the Chromosome of Enterobacter Species | Q31161624 | ||
Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis | Q33262295 | ||
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america | Q34160380 | ||
Plasmid-mediated quinolone resistance | Q34888920 | ||
Antibiotic-resistant gram-negative bacterial infections in patients with cancer | Q34999880 | ||
Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland. | Q35069068 | ||
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correla | Q35077317 | ||
Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer | Q35078855 | ||
Prevalence and fluoroquinolone resistance of pseudomonas aeruginosa in a hospital of South China | Q35173914 | ||
The emergence of plasmid mediated quinolone resistance qnrA2 in extended spectrum β-lactamase producing Klebsiella pneumoniae in the Middle East | Q35799490 | ||
Association between mutations in gyrA and parC genes of Acinetobacter baumannii clinical isolates and ciprofloxacin resistance. | Q35875907 | ||
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate | Q36094929 | ||
Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments | Q36105056 | ||
Prevalence of qnr and aac(6')-Ib-cr Genes in Clinical Isolates of Klebsiella Pneumoniae from Imam Hussein Hospital in Tehran | Q36234519 | ||
Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm | Q36850490 | ||
Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii | Q37156234 | ||
Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001-2015 | Q37215669 | ||
oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae | Q37274700 | ||
Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) Reverses Resistance to Colistin, but Not to Carbapenems and Tigecycline in Multidrug-Resistant Enterobacteriaceae | Q37639619 | ||
Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success | Q38212925 | ||
Prevalence of plasmid-mediated quinolone resistance determinants among oxyiminocephalosporin-resistant Enterobacteriaceae in Argentina | Q38567747 | ||
Molecular Identification of Aminoglycoside-Modifying Enzymes and Plasmid-Mediated Quinolone Resistance Genes among Klebsiella pneumoniae Clinical Isolates Recovered from Egyptian Patients. | Q38714815 | ||
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance | Q38906198 | ||
Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum β-lactamase-producing Enterobacteriaceae in a Tunisian hospital | Q39002483 | ||
Plasmid-Mediated Quinolone Resistance in Gram-Negative Pathogens Isolated from Cancer Patients in Egypt. | Q53693134 | ||
Occurrence of virulence genes, 16S rRNA methylases, and plasmid-mediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan. | Q54243354 | ||
Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones. | Q54316986 | ||
Mechanism of action of and resistance to quinolones | Q58057075 | ||
gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon | Q84597146 | ||
Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt | Q39054198 | ||
Mechanisms of quinolone action and resistance: where do we stand? | Q39306821 | ||
First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals | Q39530865 | ||
Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates | Q39895046 | ||
Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis. | Q40490160 | ||
Occurrence of the Plasmid-Mediated Fluoroquinolone Resistance qepA1 Gene in Two Clonal Clinical Isolates of CTX-M-15-Producing Escherichia coli from Algeria. | Q40508258 | ||
Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Clinical Enterobacteria from Argentina | Q40510332 | ||
High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli and Klebsiella pneumoniae Isolates from Pediatric Patients in China | Q40679233 | ||
Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Acinetobacter baumannii in China | Q41304883 | ||
Detection of highly ciprofloxacin resistance acinetobacter baumannii isolated from patients with burn wound infections in presence and absence of efflux pump inhibitor | Q41470028 | ||
Detection of plasmid-mediated quinolone resistance determinants and qnrS expression in Enterobacteriaceae clinical isolates | Q41602778 | ||
Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland. | Q41621926 | ||
Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates | Q41934962 | ||
Discrimination between native and Tn6010-associated oqxAB in Klebsiella spp., Raoultella spp., and other Enterobacteriaceae by using a two-step strategy | Q42002757 | ||
Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital | Q43504697 | ||
Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography | Q44176682 | ||
Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. | Q44266033 | ||
Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance | Q45392612 | ||
High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria | Q46157116 | ||
Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus | Q46160054 | ||
Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa | Q46397999 | ||
Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea | Q46610974 | ||
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli | Q47875119 | ||
Novel ISCR1-linked resistance genes found in multidrug-resistant Gram-negative bacteria in southern China | Q48047132 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 12268 | |
P577 | publication date | 2018-08-16 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients | |
P478 | volume | 8 |
Q99241137 | Fluoroquinolone Resistance in Clinical Isolates of Klebsiella Pneumonia e | cites work | P2860 |
Search more.